149
Participants
Start Date
March 30, 2023
Primary Completion Date
December 16, 2024
Study Completion Date
June 30, 2025
PerQseal® Closure Device System
Bioabsorbable implant delivered percutaneously to achieve haemostasis of common femoral arteriotomies created by 12 to 22 F sheaths (up to 26 F arteriotomy) in patients undergoing percutaneous catheter-based interventional procedures.
Columbia University Medical Center/ NewYork Presbyterian Hospital, New York
Montefiore Medical Center (multiple centers), The Bronx
St. Gertrauden Krankenhaus (SGK), Berlin
Stony Brook University Hospital, Stony Brook
University of Buffalo, Buffalo
University of Rochester Medical Center, Rochester
UPMC Pinnacle Health, Mechanicsburg
Lankenau Institute for Medical Research, Wynnewood
UPenn - Perelman Center for Advanced Medicine,, Philadelphia
The Cleveland Clinic, Cleveland
The Texas Heart Institute, Houston
HonorHealth, Scottsdale
Scripps, La Jolla
Northern Light Eastern Maine Medical Center, Bangor
Cooper University Hospital, Camden
The Valley Hospital, Paramus
St Franziskus Hospital, Münster
Leipzig University Hospital, Leipzig
Vivasure Medical Limited
INDUSTRY